Search Results (73)

Background/Objectives: Degenerative cervical myelopathy (DCM) is the leading cause of non-traumatic spinal cord dysfunction in adults. Both anterior and posterior surgical approaches are widely used for its treatment, yet their comparative impact on clinical outcomes and complication profiles remains clinically relevant. This study aimed to describe early and one-year postoperative outcomes between anterior and posterior surgical strategies in a consecutive single-center cohort. Methods: We conducted a retrospective single-center study of 102 consecutive adult patients surgically treated for DCM between 2013 and 2024, with complete datasets and a minimum one-year follow-up. Surgical approaches were classified as anterior, posterior, or combined. Clinical outcomes were assessed using the modified Japanese Orthopaedic Association scale (mJOA), Neck Disability Index (NDI), and Numeric Rating Scale for arm pain (NRS-arm) preoperatively, at 4–6 weeks and at one year. Complications were systematically recorded and stratified by approach. Nonparametric tests were used for all comparisons (significance threshold p < 0.05). Results: Anterior procedures were performed in 82 patients (80.4%), posterior in 18 (17.6%), and combined in 2 (2.0%). No significant between-group differences were observed in neurological, functional, or pain outcomes at either time point (ΔmJOA p = 0.268; ΔNDI p = 0.632; ΔNRS p = 0.562 at one year). Complications occurred in 13 patients (12.7%), with approach-specific profiles: anterior surgery was associated with hematoma, dysphagia, and dysphonia, posterior surgery with CSF leak, wound infection, and kyphosis. No C5 palsy was recorded. Conclusions: Both anterior and posterior surgical approaches were followed by neurological and functional improvement at one year. Given the descriptive nature of the study and the baseline differences between groups, these findings should not be read as a formal comparison of effectiveness, but they reinforce the importance of individualized, pathology-driven surgical planning in DCM. Full article

Background/Objectives: degenerative cervical myelopathy (DCM) is the leading cause of spinal cord impairment in adults, often resulting in disability and reduced quality of life (QoL). Surgery is recommended for moderate and severe cases, while its role in mild DCM remains debated. Emerging evidence suggests that early surgery may improve outcomes, particularly QoL. Methods: We conducted a retrospective, single-center observational study of a cohort of patients undergoing cervical spine surgery for DCM between January 2020 and August 2023 at a single institution (Policlinico di Monza, Italy). Demographic, clinical, radiological and surgical data, as well as complications and outcomes, were analyzed. Neurological status was assessed using the modified Japanese Orthopedic Association (mJOA) score and QoL was evaluated using the Short Form-36 (SF-36) questionnaire preoperatively, at discharge, and at follow-up. Results: 51 patients were included (mean age 58.1 years; 41% female), with anterior surgery performed in 67%. Mild preoperative mJOA score was observed in 74% of patients. At follow-up, 65% achieved complete recovery, 29% improved, and 6% remained stable. No neurological deterioration was recorded. Univariate analysis identified age, anterior cervical discectomy and fusion (ACDF), and mild preoperative mJOA score as significant predictors of recovery. Multivariate logistic regression analysis identified mild preoperative mJOA score as a strong independent predictor of complete clinical recovery (OR = 240.64, 95% CI: 6.82–8496.22, p = 0.002). SF-36 showed significant improvements in emotional well-being, social functioning, pain, and general health, particularly in mild cases. Complications were low (5.8%) and limited to transient dysphagia. Conclusions: early surgical treatment in selected patients with mild DCM may be associated with favorable neurological and quality-of-life outcomes, although larger prospective studies are needed. Full article

Background/Objectives: i-Factor™ Bone Graft is a composite bone substitute containing P-15 synthetic collagen fragment that has demonstrated noninferiority to local autograft in single-level anterior cervical discectomy and fusion (ACDF); however, direct head-to-head comparisons with demineralized bone matrix (DBM) using contemporary 3D-printed titanium cages are lacking. The aim of this retrospective study was to compare radiographic fusion rates, segmental stability, and clinical outcomes between i-Factor™ and DBM in single-level ACDF, with a particular focus on the early time course of fusion. Methods: A retrospective propensity score-matched cohort study was conducted in patients with single-level cervical degenerative disc disease (cervical disc herniation, cervical spondylotic radiculopathy, or cervical spondylotic myelopathy) operated between December 2021 and January 2024 at a single tertiary care hospital. Seventy-six consecutive patients undergoing single-level ACDF with 3D-printed titanium cages were matched 1:1 (i-Factor™ vs. DBM) on age, sex, and operative level. Fusion status was assessed by serial dynamic radiographs at 1, 3, 6, and 12 months and by 3D-CT at 12 months in all patients (with additional CT at earlier timepoints when plain films were equivocal), by two independent spine surgeons blinded to graft type; inter-rater agreement (Cohen’s κ) was computed. Results: Mean follow-up was 18.1 months. Fusion rates for i-Factor™ at 3, 6, and 12 months were 94.7%, 100%, and 100%, respectively, compared to 71.1%, 84.2%, and 94.7% for DBM. The differences were statistically significant at 3 months (p = 0.047) and 6 months (p = 0.012), but not at 12 months (p = 0.493). Inter-rater agreement was almost perfect (κ = 0.86–1.00). No adverse reactions or device-related complications were observed. Conclusions: In this matched cohort, i-Factor™ was associated with significantly faster fusion than DBM in single-level ACDF, with similar 12-month fusion rates. No adverse reactions were observed, although the sample size is insufficient to exclude rare complications. Full article

Anterior cervical discectomy and fusion (ACDF) is one of the most commonly performed surgical procedures for the treatment of cervical degenerative disease, myelopathy, radiculopathy, and segmental instability. Although clinical outcomes are generally favorable, pseudarthrosis remains a relevant complication, with a reported incidence ranging from 5% to 20%. In a field with no yet clear main directions, this narrative review aims at giving the reader a broad picture and a wide analysis of the recent advances in cervical spinal fusion, with particular focus on biomaterials, intervertebral cage technologies, cervical spine biomechanics and imaging methods used for fusion assessment. The literature regarding quantitative imaging parameters and emerging applications of artificial intelligence (AI) is also reviewed. Current bone grafts include autologous grafts, allografts, xenografts and polymeric grafts, while the materials for the intervertebral cages comprehend titanium, polyetheretherketone and silicon nitride, with reported fusion rates distributed in a very large range. Computed tomography (CT) remains the standard imaging modality to assess whether fusion has occurred, due to its high spatial resolution. However, the lack of shared diagnostic criteria and the significant interobserver variability continue to limit its reliability. Quantitative parameters, such as Hounsfield Unit measurements and MRI-derived bone quality scores, may contribute to a more objective evaluation, although current evidence remains heterogeneous. In parallel, AI-based imaging analysis is showing promising results for quantitative assessment and longitudinal monitoring of bone fusion; however, large prospective clinical studies are still needed to confirm its clinical applicability. In conclusion, despite advances in surgical technologies and biomaterials, radiological assessment of cervical fusion still lacks universally accepted diagnostic standards. Future AI applications may improve diagnostic accuracy and reproducibility, promoting a more standardized approach in clinical practice. Full article

Background/Objectives: Degenerative cervical myelopathy (DCM) may result from posture-dependent spinal cord compromise not detectable on neutral imaging. Dynamic MRI can uncover clinically relevant mechanisms underlying otherwise unexplained myelopathy and guide management. This report illustrates a dynamic cervical myelopathy phenotype revealed by flexion–extension imaging and its impact on surgical decision-making. Methods: A 49-year-old man presented with progressive bilateral upper-limb paresthesias, intrinsic hand atrophy, and distal weakness. Neutral cervical MRI, standard radiographs, and flexion–extension MRI were performed to investigate a suspected dynamic etiology, including differentiation from Hirayama disease. Surgical treatment consisted of anterior cervical discectomy and fusion (ACDF), with clinical and radiological follow-up. Results: Neutral MRI showed intramedullary T2 hyperintensity from C4 to C6 without static canal stenosis or frank compression, while radiographs demonstrated segmental kyphosis without instability. Flexion MRI revealed reproducible spinal cord contact with a small cranially located osteophyte at C5–C6, concordant with the myelopathic signal. ACDF at C4–C6 led to clinical improvement. One year later, recurrent symptoms from adjacent-segment pathology (C3–C4 myelopathic signal and C6–C7 foraminal disc herniation) required a second ACDF, resulting in durable neurological stability. Conclusions: This case demonstrates flexion-dependent cord–osteophyte conflict causing cervical myelomalacia in the absence of static stenosis. Dynamic MRI resolved a clinical–radiological mismatch and directly informed surgical planning. Recognition of dynamic myelopathy phenotypes and vigilance for adjacent-segment disease after fusion are essential for optimizing outcomes. Full article

Background: Anterior cervical discectomy and fusion (ACDF) is widely performed and has a low incidence of postoperative infection. Anterior cervical abscess is a rare but potentially life-threatening complication, typically caused by skin or oral flora. Identification of atypical pathogens has important implications for diagnostic vigilance and antimicrobial management. Case Presentation: We report a 56-year-old man with degenerative cervical myelopathy and significant respiratory comorbidity who underwent single-level ACDF and developed progressive dysphagia and neck pain in the early postoperative period. Imaging demonstrated a prevertebral abscess requiring urgent surgical drainage. Intraoperative cultures identified Moraxella catarrhalis, a respiratory tract commensal rarely implicated in postoperative spinal infections. No evidence of esophageal perforation or superficial wound contamination was identified. The patient was treated with surgical washout and prolonged culture-directed antibiotic therapy, with full clinical recovery. To contextualize novelty, we performed a focused review of the available literature on M. catarrhalis spinal infections. Conclusions: This case expands the spectrum of pathogens implicated in postoperative cervical spine infections and highlights the need to consider respiratory tract organisms in high-risk patients, particularly those with chronic pulmonary disease or immunosuppression. Early imaging in the presence of dysphagia, prompt source control, and culture-directed antimicrobial therapy are essential to optimizing outcomes. Full article

Background/Objectives: Conventional static magnetic resonance imaging may underestimate the severity of cervical cord compression by failing to account for positional changes in the spinal canal. Dynamic MRI (dMRI) captures cervical motion, allowing evaluation of cord compression under physiological loading. This systematic review aimed to synthesize evidence on how dMRI modifies the assessment of spinal canal narrowing and signal change, and how these findings correlate with impairment and postoperative outcomes in degenerative cervical myelopathy. Methods: A systematic literature search was conducted across PubMed, Scopus, and Embase databases according to PRISMA guidelines. Studies evaluating the role of dMRI (flexion–extension MRI) in diagnosing or predicting outcomes of cervical degenerative pathology were included. Data were extracted on imaging protocols, diagnostic findings, quantitative parameters, and clinical outcomes. Results: Nineteen studies met the inclusion criteria. dMRI consistently revealed motion-dependent stenosis and intramedullary signal changes not visible on static imaging. Extension imaging frequently demonstrated disease progression, showing altered spinal cord area, cerebrospinal fluid (CSF) reserve, and additional compression levels. Dynamic sequences enhanced sensitivity for pathological segment detection and improved correlation with clinical severity. Preoperative dMRI findings, particularly extension-related compression and T2 hyperintensity, predicted postoperative neurological recovery and influenced surgical planning in up to one third of cases. Conclusions: Dynamic MRI provides superior diagnostic sensitivity and prognostic information compared with static imaging by revealing motion-induced spinal cord compression and microstructural alterations. It should be considered when clinical findings exceed static MRI severity or when the symptomatic level is uncertain. Standardization of protocols and large prospective studies are needed to define evidence-based clinical indications. Full article

Background/Objectives: The molecular cascades involved in the induction and maintenance of neuroinflammation resulting from chronic compression of the cervical spinal cord in the setting of degenerative cervical myelopathy (DCM) have yet to be defined. Here, we determined the role of the fractalkine receptor, CX3CR1, during the neuroinflammatory response in a novel mouse model of DCM and demonstrated the relevance of this mechanism with human DCM tissue. Methods: Using our murine DCM model alongside the CX3CR1-knockout mice and a neutralizing antibody of CX3CR1 in wild-type mice, we examined protein, neurobehavioural and immunohistochemical readouts. The animal data were then complemented with immunohistochemical results from human post-mortem spinal cord tissue from individuals with DCM. Results: Humans and mice with DCM exhibited an up-regulation of CX3CR1 as well as markers of activated microglia/macrophages in the cervical spinal cord. Knockout and neutralization of CX3CR1 hindered microglia/macrophage activation and accumulation at the site of spinal cord compression. DCM mice exhibited decreased body speed and increased stance phase duration, which mirrors human DCM gait deficits. Strikingly, both CX3CR1 deficiency and CX3CR1 neutralization alleviated these gait deficits in DCM mice. Conclusions: Collectively, these data provide strong evidence that CX3CR1 plays a critical role in the secondary injury of neural structures in the setting of DCM. Further, targeting of CX3CR1 represents a promising therapeutic strategy to enhance neurological outcomes in DCM. Full article

Background: Acute transverse myelitis (ATM) can closely mimic degenerative spinal disorders, often leading to diagnostic delay or inappropriate surgical decisions. However, its epidemiologic characteristics among patients undergoing spinal surgery remain unknown. This nationwide, population-based study investigated the incidence, perioperative diagnostic trends, and risk factors of ATM in patients treated surgically for degenerative spinal disease. Methods: Data were extracted from the Korean Health Insurance Review and Assessment Service database (2014–2018). Adults (>19 years) who underwent surgery for degenerative spinal disease were identified, and those with malignancy, infection, fracture, or prior myelitis were excluded. The two-year perioperative observation period (−360 to +360 days) was divided into 24 consecutive 30-day intervals. Patients were classified by ATM occurrence, and multivariable logistic regression with bootstrap validation was used to identify independent risk factors. Incidence rates were expressed per 100,000 person-years. Results: Among 201,769 eligible patients, 269 (0.13%) developed ATM, yielding an incidence of 67 (95% CI: 59–75) per 100,000 person-years—substantially higher than in the general population. Younger age, male sex, myocardial infarction, cerebrovascular disease, rheumatologic disease, and cervical or thoracic spinal lesions were independent predictors. Notably, 28.3% of ATM cases were diagnosed within 30 days before surgery, and 50.9% within the four-month window from three months preoperatively to one month postoperatively, indicating a marked temporal clustering around surgery. Conclusions: ATM occurred far more frequently among patients undergoing surgery for degenerative spinal disease than in the general population, with diagnoses peaking immediately before surgery. This pattern likely reflects diagnostic delay rather than true perioperative onset. Because ATM can clinically and radiologically resemble degenerative myelopathy, clinicians should maintain a high index of suspicion in patients presenting with atypical or rapidly progressive neurological deterioration. Early recognition may prevent unnecessary surgery and improve neurological outcomes. Full article

Multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and degenerative cervical myelopathy (DCM) share features that may confound diagnosis. DCM is caused by degenerative changes in the cervical spine leading to spinal cord compression and injury, resulting in significant disability. Misdiagnosis of DCM for a similar neurological condition can lead to further spinal cord damage from delayed surgical treatment. Here we review the diagnostic criteria, clinical signs and symptoms, and imaging typical for DCM, and two of its clinical mimics, MS and ALS. Shared motor symptoms of all three conditions can make diagnosis difficult, especially early in disease course. Noteworthy differences include neck and shoulder pain in DCM, visual disturbances in MS, and bulbar symptoms and the absence of sensory deficits in ALS. In DCM and MS, MRI is used to support the diagnosis, with specific findings on MRI that differentiate DCM versus MS. In ALS, MRI is used to rule out differential diagnoses. Applying the diagnostic criteria for MS and ALS, as well as understanding the typical presentation and MRI findings of DCM, is crucial. Through discussion of these conditions, this review aims to help limit misdiagnosis rates, allowing for early management, which can improve long-term patient outcomes. Full article

Degenerative cervical myelopathy (DCM) is the leading cause of nontraumatic spinal cord dysfunction and remains clinically heterogeneous in presentation and course. This review synthesizes current evidence on predictors of neurological outcomes across conventional prognostic factors (clinical and macrostructural metrics) and quantitative neuroimaging (microstructural metrics), as well as how machine learning (ML) models integrate these predictors into a precision medicine framework to aid in DCM management. We explore evidence on conventional clinical and radiographic factors. Although several signs and scales are associated with clinical outcomes, cross-study inconsistency and the limits of linear models blunt their standalone utility, underscoring the need for multifactorial modelling. We then assess quantitative MRI biomarkers, including diffusion tensor imaging, magnetization transfer, and myelin water imaging, which index axonal integrity and myelination, thereby enriching risk stratification and prediction. Building on these measurements, we examine ML models combining clinical, imaging, and demographic features to predict postoperative outcomes and, increasingly, the natural history of mild DCM. Finally, current gaps and necessary future directions are outlined, including protocol harmonization, prospective multicentre validation, and clinician–patient education to support equitable uptake. Collectively, this review advances in DCM diagnosis and prognosis, highlighting the role of precision medicine tools for personalized patient care. Full article

Intraoperative ultrasound (IOUS) has developed from a rudimentary adjunct into a versatile modality that now plays a crucial role in neurosurgery. Offering real-time, radiation-free and repeatable imaging at the surgical site, it provides distinct advantages over intraoperative magnetic resonance (MRI) and computed tomography (CT) in terms of accessibility, workflow integration and cost. The clinical spectrum of IOUS is broad: in cranial surgery it enhances the extent of resection of gliomas and metastases, supports dissection in meningiomas and enables localization of MRI-negative pituitary adenomas; in spinal surgery, it guides resection of intradural and intramedullary tumors, assists in myelotomy planning and confirms decompression in degenerative conditions such as cervical myelopathy and ossification of the posterior longitudinal ligament. IOUS also offers unique insights into cerebrospinal fluid disorders, including arachnoid webs, cysts, syringomyelia and Chiari malformation, where it visualizes cord compression and CSF flow restoration. In trauma and oncological emergencies, it provides immediate confirmation of decompression, directly influencing surgical decisions. Recent innovations, including contrast-enhanced ultrasound, elastography, three-dimensional navigated systems and experimental integration with artificial intelligence and robotics, are extending its functional scope. Despite heterogeneity of evidence and operator dependence, IOUS is steadily transitioning from an adjunctive tool to a cornerstone of multimodal intraoperative imaging, bridging precision, accessibility and innovation in contemporary neurosurgical practice. Full article

Degenerative cervical myelopathy (DCM) is a common cause of spinal cord dysfunction in adults and is frequently accompanied by pain, a symptom that remains under-recognised despite its profound impact on quality of life. Conventional magnetic resonance imaging (MRI) is indispensable for identifying structural spinal cord compression; however, it is unable to detect early microstructural alterations, particularly those that may contribute to pain pathophysiology. This narrative review critically appraises the limitations of standard MRI in the diagnostic assessment of DCM and examines the expanding role of advanced imaging modalities—most notably diffusion tensor imaging (DTI)—in evaluating spinal cord integrity. DTI-derived parameters, including fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD), demonstrate sensitivity to axonal and myelin injury. For example, reductions in FA and AD have been linked to axonal disruption in sensory pathways, while elevations in RD suggest demyelination, a hallmark of neuropathic pain. Despite this potential, the widespread implementation of DTI is constrained by technical heterogeneity, limited accessibility, and the absence of standardised protocols. Future research priorities include the incorporation of pain-specific imaging endpoints, longitudinal validation across diverse cohorts, and integration with artificial intelligence frameworks to enable automated analysis and predictive modelling. Collectively, these advances hold promise for enabling earlier diagnosis, refined symptom stratification, and more personalised therapeutic strategies in DCM. Full article

Study Design: Retrospective Case–Control. Objectives: Sleep disturbances negatively impact quality of life and increase illness susceptibility. Chronic pain is a risk factor for sleep disruption, particularly in patients with degenerative spinal conditions. Existing studies suggest that degenerative cervical myelopathy (DCM) patients often experience sleep disturbances, possibly due to spinal cord compression and pain. However, most research is limited to small, single-center studies, creating a need for broader analyses. Methods: We utilized the Merative Explorys Dataset, focusing on electronic health record data of patients diagnosed with DCM and sleep disorders identified via ICD codes. Comorbidities analyzed included depression/bipolar disorder, chronic pulmonary disease, migraine, osteoarthritis, hypertension, malignancy, diabetes, and cerebrovascular disease. Patient demographic information (age, race, sex, and body mass index (BMI)) was included as covariates. Logistic regression analyses were performed to evaluate the association between each comorbidity and the risk of sleep disturbance. Results: Among 40,551 DCM patients, significant predictors of sleep disturbance included higher BMI (OR: 1.05, 95% CI: 1.05–1.06), depression/bipolar disorder (OR: 1.65, 95% CI: 1.56–1.74), chronic pulmonary disease (OR: 1.26, 95% CI: 1.20–1.33), migraine (OR: 1.32, 95% CI: 1.22–1.43), and hypertension (OR: 1.16, 95% CI: 1.10–1.23). Conclusions: This large-scale analysis demonstrates the multifactorial nature of sleep disturbances in DCM, highlighting strong associations with BMI and respiratory conditions, suggesting a contributory role of sleep-disordered breathing. The identification of migraines as a risk factor highlights the need for multidisciplinary management. Addressing modifiable risk factors such as BMI and mental health may improve sleep quality in DCM patients. Full article